This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Emory University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Rachel Commander: Innovator in Cancer Management
Introduction
Rachel Commander is a prominent inventor based in Atlanta, GA, who has made significant contributions to the field of cancer management. With a focus on bis-biguanide compounds, her work aims to improve treatment options for patients diagnosed with lung cancer.
Latest Patents
Rachel Commander holds a patent for "Bis-biguanide compounds, pharmaceutical compositions and uses in managing cancer." This patent outlines methods for managing cancer using bis-biguanide compounds, such as alexidine. The disclosure emphasizes the treatment of lung cancer by administering an effective amount of these compounds to patients in need. Specifically, it addresses methods for treating small cell lung cancer, highlighting the importance of targeted therapies in oncology.
Career Highlights
Rachel is affiliated with Emory University, where she conducts her research and develops innovative solutions for cancer treatment. Her dedication to advancing medical science is evident in her patent and ongoing research efforts.
Collaborations
Rachel collaborates with esteemed colleagues, including Adam Marcus and Jessica Konen, to further her research and enhance the impact of her work in the medical community.
Conclusion
Rachel Commander's innovative approach to cancer management through bis-biguanide compounds showcases her commitment to improving patient outcomes. Her contributions to the field are invaluable and reflect her dedication to advancing medical science.